Company Filing History:
1 out of 12,160 
1 out of 378 
1 out of 16 Years Active: 2016-2024
Title: Annett Richter: Innovator in Cardiopulmonary Treatments
Introduction
Annett Richter is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of cardiopulmonary disorders through her innovative patents. With a total of 2 patents, her work focuses on improving treatment methods for serious health conditions.
Latest Patents
Richter's latest patents include a groundbreaking treatment for cardiopulmonary disorders. This invention relates to the use of a specific compound, (5S)-{[2-(4-carboxyphenyl)ethyl][2-(2-{[3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]-amino}-5,6,7,8-tetrahydroquinoline-2-carboxylic acid, in inhalative treatments for conditions such as pulmonary arterial hypertension and chronic obstructive pulmonary disease. The patent outlines a method of administering this compound in a dosage form that is both effective and safe for patients.
Another significant patent involves formulations of fluorinated stilbene suitable for PET imaging. This invention focuses on the development of formulations that can be administered parenterally, enhancing the capabilities of imaging techniques for diagnosing conditions related to Amyloid beta.
Career Highlights
Throughout her career, Annett Richter has worked with prominent companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations and research.
Collaborations
Richter has collaborated with notable colleagues, including Eva Maria Becker-Pelster and Hanna Tinel. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical treatments.
Conclusion
Annett Richter's contributions to the field of cardiopulmonary treatments and imaging techniques highlight her innovative spirit and dedication to improving patient care. Her patents reflect a commitment to advancing medical science and enhancing treatment options for serious health conditions.